
Sign up to save your podcasts
Or


Celgene buys Juno Theraputics. Halliburton delivers results in the 4th quarter and optimism for 2018. Abercrombie & Fitch soars 10% on a better-than-expected holiday season. Jason Moser and Taylor Muckerman analyze those stories and discuss opportunities in the energy industry.
By The Motley Fool4.7
16041,604 ratings
Celgene buys Juno Theraputics. Halliburton delivers results in the 4th quarter and optimism for 2018. Abercrombie & Fitch soars 10% on a better-than-expected holiday season. Jason Moser and Taylor Muckerman analyze those stories and discuss opportunities in the energy industry.

3,237 Listeners

1,497 Listeners

806 Listeners

941 Listeners

533 Listeners

1,182 Listeners

2,186 Listeners

825 Listeners

1,428 Listeners

1,051 Listeners

9,714 Listeners

195 Listeners

829 Listeners

83 Listeners

49 Listeners

1,024 Listeners

50 Listeners